USDA Grants Expanded Approval for Elanco's Canine Parvovirus Monoclonal Antibody, Enhancing Preventative Measures for Puppies Across the Nation

Reuters

06/27

USDA Grants Expanded Approval for Elanco's Canine Parvovirus Monoclonal Antibody, Enhancing Preventative Measures for Puppies Across the Nation

Elanco Animal Health Inc. has announced a significant regulatory milestone with the U.S. Department of Agriculture (USDA) granting expanded approval for its Canine Parvovirus Monoclonal Antibody (CPMA). This approval allows the use of CPMA for passive immunity, providing veterinarians with a preventative option to protect puppies exposed to the deadly canine parvovirus. In line with their mission "Defend Puppies. Defeat Parvo.", Elanco has also donated over $3 million worth of CPMA to 2,300 clinics and shelters in high parvo risk areas, broadening access to this life-saving treatment. This initiative has already seen success, with the largest recorded group of 27 parvo-infected puppies saved at the SPCA of Brevard Adoption Center in Florida.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Elanco Animal Health Inc. published the original content used to generate this news brief on June 27, 2025, and is solely responsible for the information contained therein.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2546094749"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2546094749\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2546094749?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-06-27 21:42","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2546094749","market":"nz","top_or_hot":-1,"title":"USDA Grants Expanded Approval for Elanco's Canine Parvovirus Monoclonal Antibody, Enhancing Preventative Measures for Puppies Across the Nation","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      USDA Grants Expanded Approval for Elanco's Canine Parvovirus Monoclonal Antibody, Enhancing Preventative Measures for Puppies Across the Nation\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        <a href=\"https://laohu8.com/S/ELAN\">Elanco Animal Health Inc</a>. has announced a significant regulatory milestone with the U.S. Department of Agriculture (USDA) granting expanded approval for its Canine Parvovirus Monoclonal Antibody (CPMA). This approval allows the use of CPMA for passive immunity, providing veterinarians with a preventative option to protect puppies exposed to the deadly canine parvovirus. In line with their mission \"Defend Puppies. Defeat Parvo.\", Elanco has also donated over $3 million worth of CPMA to 2,300 clinics and shelters in high parvo risk areas, broadening access to this life-saving treatment. This initiative has already seen success, with the largest recorded group of 27 parvo-infected puppies saved at the SPCA of Brevard Adoption Center in Florida.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Elanco Animal Health Inc. published the original content used to generate this news brief on June 27, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>USDA Grants Expanded Approval for Elanco's Canine Parvovirus Monoclonal Antibody, Enhancing Preventative Measures for Puppies Across the Nation</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUSDA Grants Expanded Approval for Elanco's Canine Parvovirus Monoclonal Antibody, Enhancing Preventative Measures for Puppies Across the Nation\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-06-27 21:42</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      USDA Grants Expanded Approval for Elanco's Canine Parvovirus Monoclonal Antibody, Enhancing Preventative Measures for Puppies Across the Nation\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        <a href=\"https://laohu8.com/S/ELAN\">Elanco Animal Health Inc</a>. has announced a significant regulatory milestone with the U.S. Department of Agriculture (USDA) granting expanded approval for its Canine Parvovirus Monoclonal Antibody (CPMA). This approval allows the use of CPMA for passive immunity, providing veterinarians with a preventative option to protect puppies exposed to the deadly canine parvovirus. In line with their mission \"Defend Puppies. Defeat Parvo.\", Elanco has also donated over $3 million worth of CPMA to 2,300 clinics and shelters in high parvo risk areas, broadening access to this life-saving treatment. This initiative has already seen success, with the largest recorded group of 27 parvo-infected puppies saved at the SPCA of Brevard Adoption Center in Florida.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Elanco Animal Health Inc. published the original content used to generate this news brief on June 27, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4007","symbol_name":"制药","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250627:nNDL9NKfSB:1","article_id":"2546094749","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2546094749","pubTimestamp":1751031744,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"USDA Grants Expanded Approval for Elanco's Canine Parvovirus Monoclonal Antibody, Enhancing Preventative Measures for Puppies Across the Nation. Elanco Animal Health Inc. has announced a significant regulatory milestone with the U.S. Department of Agriculture  granting expanded approval for its Canine Parvovirus Monoclonal Antibody . This approval allows the use of CPMA for passive immunity, providing veterinarians with a preventative option to protect puppies exposed to the deadly canine parvovirus. In line with their mission \"Defend Puppies. Defeat Parvo.\", Elanco has also donated over $3 million worth of CPMA to 2,300 clinics and shelters in high parvo risk areas, broadening access to this life-saving treatment. This initiative has already seen success, with the largest recorded group of 27 parvo-infected puppies saved at the SPCA of Brevard Adoption Center in Florida.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4007":"制药","ELAN":"Elanco Animal Health Inc","BK4561":"索罗斯持仓"},"translate_title":"美国农业部扩大对Elanco犬细小病毒单克隆抗体的批准，加强全国幼犬的预防措施","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ELAN":0.9},"content_text":"USDA Grants Expanded Approval for Elanco's Canine Parvovirus Monoclonal Antibody, Enhancing Preventative Measures for Puppies Across the Nation\n    \n\nElanco Animal Health Inc. has announced a significant regulatory milestone with the U.S. Department of Agriculture (USDA) granting expanded approval for its Canine Parvovirus Monoclonal Antibody (CPMA). This approval allows the use of CPMA for passive immunity, providing veterinarians with a preventative option to protect puppies exposed to the deadly canine parvovirus. In line with their mission \"Defend Puppies. Defeat Parvo.\", Elanco has also donated over $3 million worth of CPMA to 2,300 clinics and shelters in high parvo risk areas, broadening access to this life-saving treatment. This initiative has already seen success, with the largest recorded group of 27 parvo-infected puppies saved at the SPCA of Brevard Adoption Center in Florida.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Elanco Animal Health Inc. published the original content used to generate this news brief on June 27, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}